Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress CRNX Q1 2026 Earnings NarrowerThanExpected Loss as Crinetics Advances Pipeline INTA Q1 2026 Earnings Narrow EPS Beat Highlights Operational Discipline Amid Market Caution FFBC Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher LAW Q1 2026 Earnings EPS Beat Masks Revenue Disappointment Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline